WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants
(2003; 80 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentForeword
Open this folder and view contents1. General introduction
Close this folder2. Good agricultural practices for medicinal plants
Close this folder2.1. Identification/authentication of cultivated medicinal plants
View the document2.1.1. Selection of medicinal plants
View the document2.1.2. Botanical identity
View the document2.1.3. Specimens
View the document2.2. Seeds and other propagation materials
Open this folder and view contents2.3. Cultivation
View the document2.4. Harvest
View the document2.5. Personnel
Open this folder and view contents3. Good collection practices for medicinal plants
Open this folder and view contents4. Common technical aspects of good agricultural practices for medicinal plants and good collection practices for medicinal plants
Open this folder and view contents5. Other relevant issues
View the documentBibliography
View the documentAnnex 1. Good Agricultural Practice for Traditional Chinese Medicinal Materials, People's Republic of China
Open this folder and view contentsAnnex 2. Points to Consider on Good Agricultural and Collection Practice for Starting Materials of Herbal Origin
View the documentAnnex 3. Good Agricultural and Collection Practices for Medicinal Plants (GACP), Japan
View the documentAnnex 4. A model structure for monographs on good agricultural practices for specific medicinal plants
View the documentAnnex 5. Sample record for cultivated medicinal plants
View the documentAnnex 6. Participants in the WHO Consultation on Good Agricultural and Field Collection Practices for Medicinal Plants
 

2.1.1. Selection of medicinal plants

Where applicable, the species or botanical variety selected for cultivation should be the same as that specified in the national pharmacopoeia or recommended by other authoritative national documents of the end-user's country. In the absence of such national documents, the selection of species or botanical varieties specified in the pharmacopoeia or other authoritative documents of other countries should be considered. In the case of newly introduced medicinal plants, the species or botanical variety selected for cultivation should be identified and documented as the source material used or described in traditional medicine of the original country.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014